D024882PhysiologyG06.225.420G06.920.225G07.690.773.984.269.42013370.978595Drug Resistance, ViralFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson31279814Komatsu TE, Hodowanec AC, Colberg-Poley AM, Pikis A, Singer ME, O'Rear JJ, Donaldson EFAntiviral researchIn-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products. Antiviral Res. 2019 09; 169:104549.Antiviral Res2019-07-04T00:00:002019In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products.DianaHuangDiana Huang349330Huang, DianaAssistant ProfessorJamesBremerJames W. Bremer349565Bremer, JamesProfessorNellLurainNell Lurain349567Lurain, NellProfessor EmeritusNancyReauNancy Reau349580Reau, NancyProfessor6Assistant Professor4Professor24Professor Emeritustrue1Professor EmeritusProfessor Emeritus22544186Parkin N, Bremer J, Bertagnolio SClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaGenotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010. Clin Infect Dis. 2012 May; 54 Suppl 4:S266-72.Clin Infect Dis2012-05-01T00:00:002012Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.33348705Jennings C, Parkin NT, Zaccaro DJ, Capina R, Sandstrom P, Ji H, Brambilla DJ, Bremer JWVirusesApplication of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses. 2020 12 17; 12(12).Viruses2020-12-17T00:00:002020Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing.Rush University, Rush Medical CollegeRajShahRaj C. Shah41.87328300000000-87.66936330000000349027Shah, RajProfessor1.713390.04352213research area of0.7967940.053523537subject area forInternal Medicine, Division of Digestive Diseases and Nutritiontrue1ProfessorProfessor28328546Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda DJournal of acquired immune deficiency syndromes (1999)Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.J Acquir Immune Defic Syndr2017-06-01T00:00:002017Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.25491023Gagermeier JP, Rusinak JD, Lurain NS, Alex CG, Dilling DF, Wigfield CH, Love RBTransplant infectious disease : an official journal of the Transplantation SocietySubtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients. Transpl Infect Dis. 2014 Dec; 16(6):941-50.Transpl Infect Dis2014-12-10T00:00:002014Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessorMicrobial Pathogens and ImmunityFamily & Preventive Medicinetrue1ProfessorProfessor